Sari Karlsson

Summary

Affiliation: Tampere University Hospital
Country: Finland

Publications

  1. pmc Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S--Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for
    Anders Perner
    Department of Intensive Care, Centre of Clinical Intervention Research, Copenhagen University Hospital, Rigshospitalet, Denmark
    Trials 12:24. 2011
  2. pmc One-year mortality, quality of life and predicted life-time cost-utility in critically ill patients with acute respiratory failure
    Rita Linko
    Department of Anaesthesia and Intensive Care Medicine, Helsinki University Hospital, Sairaalakatu 1, Helsinki, Finland
    Crit Care 14:R60. 2010
  3. doi request reprint Vascular endothelial growth factor in severe sepsis and septic shock
    Sari Karlsson
    Department of Intensive Care Medicine, Tampere University Hospital, Finland
    Anesth Analg 106:1820-6. 2008
  4. ncbi request reprint Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis study
    Sari Karlsson
    Aurinkokatu 3B38, 13100, Hameenlinna, Finland
    Intensive Care Med 33:435-43. 2007
  5. doi request reprint HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis
    Sari Karlsson
    Department of Intensive Care Medicine, Tampere University Hospital, Teiskontie 35, Tampere, Finland
    Intensive Care Med 34:1046-53. 2008
  6. pmc Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study
    Sari Karlsson
    Department of Intensive Care Medicine, Tampere University Hospital, Teiskontie 35, 33521 Tampere, Finland
    Crit Care 14:R205. 2010
  7. doi request reprint Long-term outcome and quality-adjusted life years after severe sepsis
    Sari Karlsson
    Department of Intensive Care Medicine, Tampere University Hospital, Tampere, Finland
    Crit Care Med 37:1268-74. 2009
  8. ncbi request reprint A multibiomarker-based outcome risk stratification model for adult septic shock*
    Hector R Wong
    1Division of Critical Care Medicine, Cincinnati Children s Hospital Medical Center and Cincinnati Children s Hospital Research Foundation, Cincinnati, OH 2Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 3Department of Emergency Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 4Intensive Care Units, Division of Anaesthesia and Intensive Care Medicine, Department of Surgery, Helsinki University Central Hospital, Helsinki, Finland 5Pulmonary, Allergy, and Critical Care Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 6University of British Columbia, Vancouver, BC, Canada 7Critical Care Research Laboratories, Centre for Heart Lung Innovation, St Paul s Hospital, Vancouver, BC, Canada 8Department of Intensive Care Medicine, Tampere University Hospital, Tampere, Finland 9Department of Intensive Care Medicine, Kuopio University Hospital, Kuopio, Finland 10Department of Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA
    Crit Care Med 42:781-9. 2014
  9. doi request reprint Free cortisol in sepsis and septic shock
    Stepani Bendel
    Department of Intensive Care, Kuopio University Hospital, PL 16222 Kuopio, Finland
    Anesth Analg 106:1813-9. 2008
  10. doi request reprint Cell-free plasma DNA as a predictor of outcome in severe sepsis and septic shock
    Katri Saukkonen
    Departments of Medicine and Emergency Care, Helsinki University Central Hospital, Helsinki, Finland
    Clin Chem 54:1000-7. 2008

Collaborators

  • E Ruokonen
  • Ville Pettila
  • Jyrki Tenhunen
  • Marjut Varpula
  • Ilkka Parviainen
  • Marja S Hynninen
  • Nuala J Meyer
  • John H Boyd
  • James A Russell
  • Jason D Christie
  • Keith R Walley
  • Tero Ala-Kokko
  • Rita Linko
  • K A Saukkonen
  • Pekka Loisa
  • Hector R Wong
  • Anders Perner
  • Stepani Bendel
  • Michael G S Shashaty
  • Patrick Lahni
  • Christopher D Fjell
  • Christopher J Lindsell
  • Kimberly W Hart
  • Simone A Thair
  • Hans Henrik Bulow
  • Pål Klepstad
  • Anne Berit Guttormsen
  • Gudmundur Klemenzson
  • Siv Leivdal
  • Anders Aneman
  • Malgorzata Pawlowicz
  • Jørn Wetterslev
  • Sigurbergur Karason
  • Anne Lene Kjældgaard
  • Maija Kaukonen
  • Morten Steensen
  • Jan Wernerman
  • Peter Søe-Jensen
  • Claude Kancir
  • Jørgen Wiis
  • Hamid Tousi
  • Asger Bendtsen
  • Kristian R Madsen
  • Bjarne Fogh
  • Susanne Iversen
  • Jonas Nielsen
  • Pawel Berezowicz
  • Karen Doris Bødker
  • Ole Schøidt
  • Lars Broksø Holst
  • Robert Winding
  • Marcela Carlsson
  • Morten Bestle
  • Nils H Larsen
  • John Asger Petersen
  • Frank Pott
  • Per Martin Bådstøløkken
  • Nicolai Haase
  • Juha Rutanen
  • Kari Saarinen
  • Ari Alaspää
  • Seppo Hovilehto
  • Tuula Korhonen
  • Jouko Laurila
  • Markku Suvela
  • Outi Kiviniemi
  • Tero Varpula
  • Pentti Kairi
  • Tadeusz Kaminski
  • Jorma Heikkinen
  • Raili Laru Sompa
  • Pertti Arvola
  • Tero Ala Kokko
  • Vesa Lund
  • Heikki Laine
  • Seija Alila
  • Jussi Pentti

Detail Information

Publications12

  1. pmc Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S--Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for
    Anders Perner
    Department of Intensive Care, Centre of Clinical Intervention Research, Copenhagen University Hospital, Rigshospitalet, Denmark
    Trials 12:24. 2011
    ..Now lower molecular weight HES 130/0.4 is the preferred colloid in Scandinavian intensive care units (ICUs) and 1st choice fluid for patients with severe sepsis. However, HES 130/0.4 is largely unstudied in patients with severe sepsis...
  2. pmc One-year mortality, quality of life and predicted life-time cost-utility in critically ill patients with acute respiratory failure
    Rita Linko
    Department of Anaesthesia and Intensive Care Medicine, Helsinki University Hospital, Sairaalakatu 1, Helsinki, Finland
    Crit Care 14:R60. 2010
    ....
  3. doi request reprint Vascular endothelial growth factor in severe sepsis and septic shock
    Sari Karlsson
    Department of Intensive Care Medicine, Tampere University Hospital, Finland
    Anesth Analg 106:1820-6. 2008
    ..Vascular endothelial growth factor (VEGF) levels have been shown to be elevated in severe sepsis. We investigated the value of VEGF in predicting organ dysfunction and hospital mortality in adult patients with severe sepsis...
  4. ncbi request reprint Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis study
    Sari Karlsson
    Aurinkokatu 3B38, 13100, Hameenlinna, Finland
    Intensive Care Med 33:435-43. 2007
    ..To determine the incidence and outcome of severe sepsis in the adult Finnish population and to evaluate how treatment guidelines in severe sepsis are applied in clinical practice...
  5. doi request reprint HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis
    Sari Karlsson
    Department of Intensive Care Medicine, Tampere University Hospital, Teiskontie 35, Tampere, Finland
    Intensive Care Med 34:1046-53. 2008
    ..To study the predictive value of high mobility group box-1 protein (HMGB1) and hospital mortality in adult patients with severe sepsis...
  6. pmc Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study
    Sari Karlsson
    Department of Intensive Care Medicine, Tampere University Hospital, Teiskontie 35, 33521 Tampere, Finland
    Crit Care 14:R205. 2010
    ..This prospective study investigated the predictive value of procalcitonin (PCT) for survival in 242 adult patients with severe sepsis and septic shock treated in intensive care...
  7. doi request reprint Long-term outcome and quality-adjusted life years after severe sepsis
    Sari Karlsson
    Department of Intensive Care Medicine, Tampere University Hospital, Tampere, Finland
    Crit Care Med 37:1268-74. 2009
    ..To study long-term mortality, quality of life (QOL), quality-adjusted life years (QALYs), and costs per QALY in an unselected intensive care unit (ICU) patient population with severe sepsis...
  8. ncbi request reprint A multibiomarker-based outcome risk stratification model for adult septic shock*
    Hector R Wong
    1Division of Critical Care Medicine, Cincinnati Children s Hospital Medical Center and Cincinnati Children s Hospital Research Foundation, Cincinnati, OH 2Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 3Department of Emergency Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 4Intensive Care Units, Division of Anaesthesia and Intensive Care Medicine, Department of Surgery, Helsinki University Central Hospital, Helsinki, Finland 5Pulmonary, Allergy, and Critical Care Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 6University of British Columbia, Vancouver, BC, Canada 7Critical Care Research Laboratories, Centre for Heart Lung Innovation, St Paul s Hospital, Vancouver, BC, Canada 8Department of Intensive Care Medicine, Tampere University Hospital, Tampere, Finland 9Department of Intensive Care Medicine, Kuopio University Hospital, Kuopio, Finland 10Department of Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA
    Crit Care Med 42:781-9. 2014
    ..Investigators advocate that interventional trials in septic shock require effective outcome risk stratification. We derived and tested a multibiomarker-based approach to estimate mortality risk in adults with septic shock...
  9. doi request reprint Free cortisol in sepsis and septic shock
    Stepani Bendel
    Department of Intensive Care, Kuopio University Hospital, PL 16222 Kuopio, Finland
    Anesth Analg 106:1813-9. 2008
    ..We measured total and free cortisol in patients with severe sepsis and related the concentrations to outcome...
  10. doi request reprint Cell-free plasma DNA as a predictor of outcome in severe sepsis and septic shock
    Katri Saukkonen
    Departments of Medicine and Emergency Care, Helsinki University Central Hospital, Helsinki, Finland
    Clin Chem 54:1000-7. 2008
    ..We investigated the value of plasma DNA for the prediction of intensive care unit (ICU) and hospital mortality and its association with the degree of organ dysfunction and disease severity in patients with severe sepsis...
  11. ncbi request reprint Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock
    Marjut Varpula
    Department of Surgery, Helsinki University Hospital, Finland
    Crit Care Med 35:1277-83. 2007
    ..The aim of this study was to evaluate the predictive value of N-terminal pro-brain natriuretic peptide (NT-proBNP) on mortality in a large, unselected patient population with severe sepsis and septic shock...
  12. ncbi request reprint Mixed venous oxygen saturation cannot be estimated by central venous oxygen saturation in septic shock
    Marjut Varpula
    Helsinki University Hospital, POB 340, 00029 HUS, Helsinki, Finland
    Intensive Care Med 32:1336-43. 2006
    ..The aim of our study was to assess the correlation and agreement of ScvO2 and SvO2 and compare ScvO2-SvO2 difference to lactate, oxygen-derived and hemodynamic parameters in early septic shock in ICU after initial resuscitation...